Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FADUE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,438
Award facts
- Contract value 100% obligated
- $12,438.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12.4K to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on January 20, 2026, with an ultimate completion date of February 10, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999.9M through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Tagrisso is an oncology medication used in the treatment of certain lung cancers, reflecting the broader pharmaceutical supply mission of the DLA Medical Supply Chain to furnish critical medications across multiple therapeutic domains to military treatment facilities and other federal health systems. AmerisourceBergen, operating as Cencora, Inc., is one of the largest pharmaceutical distributors in the United States and has established itself as a key federal medical vendor through its competitive performance on open contracts with both the Defense Logistics Agency and Department of Veterans Affairs. The non-set-aside designation of this award indicates the contractor won through full and open competition against other qualified pharmaceutical suppliers.
Quick answers
Who was awarded contract SPE2DR26FADUE?
SPE2DR26FADUE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FADUE worth?
The government has obligated $12,438 on SPE2DR26FADUE.
Is contract SPE2DR26FADUE an order under another contract?
Yes. SPE2DR26FADUE is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADUE competed?
The extent of competition for SPE2DR26FADUE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award